Imagine indisponibilăAnti-HSP60 Antibody [CPTC-HSPD1-1]
Pe scurt
Anti-HSP60 Antibody [CPTC-HSPD1-1] este un anticorp monoclonal de șoarece împotriva țintei HSP60, cu reactivitate declarată pentru Human. Este validat pentru Flow Cytometry, IF, WB, IHC-P, are izotipul IgG1 și se livrează neconjugat. Se livrează în mărimea 100µg, la prețul de 3.826,63 lei cu TVA.
Produse destinate exclusiv cercetării. Nu se utilizează în diagnostic sau tratament.
Descriere
Mouse monoclonal [CPTC-HSPD1-1] antibody to HSP60.
Specificații
- Brand
- Antibodies
- Mărime
- 100µg
- Țintă
- HSP60
- Applications
- Flow Cytometry, IF, WB, IHC-P
- Reactivity
- Human
- Conjugate
- Unconjugated
- Host
- Mouse
- Clonality
- Monoclonal
- Product form
- Liquid
- Concentration
- 200 µg/ml
- Purification
- Protein A/G chromatography.
- Isotype
- IgG1
- Recommended dilutions
- Flow Cytometry: 1-2 µg/million cells, IF: 1-2 µg/ml, WB: 1-2 µg/ml, IHC-P: 1-2 µg/ml
- Molecular weight
- 60 kDa
- Light chain
- kappa
- Clonă
- CPTC-HSPD1-1
- Imunogen
- Recombinant full-length human HSPD1 protein.
- Specificitate
- The heat shock proteins (HSPs) comprise a group of highly conserved, abundantly expressed proteins with diverse functions, including the assembly and sequestering of multiprotein complexes, transportation of nascent polypeptide chains across cellular membranes, and the regulation of protein folding. The mitochondrial and cytosolic localization of HSP60, combined with its binding and catalysis of folding of newly synthesized proteins destined for the mitochondrial matrix, classify this protein as a molecular chaperone. An additional role of HSP 60 is to act as a cell surface marker for / Ã…L T cell recognition, as well as being involved in a danger signal cascade immune response. HSP60 has been shown to influence apoptosis in tumor cells, and changes in its expression level may serve as a biomarker, as down-regulated HSP60 expression indicates a poor prognosis as well as a risk of tumor infiltration development, especially with regard to urothelial carcinomas. In ovarian cancer, decreased expression of HSP60 correlates with aggressive tumor types, while overexpression is correlated with a better patient prognosis.
Documentație
Produse similare
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilă
Imagine indisponibilăAntibodiesA252062Anti-HSP60 Antibody [rHSPD1/6495] - BSA and Azide free
3.826,63 lei3.162,50 leiTVA inclus (21%)fără TVA